Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join Olink users, consortia, events and webinars to share insights and accelerate biomarker discovery.
Comprehensive statistical analysis & data visualization tools
Over 4,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Stroke, 2025Proteome-Wide Genetic Study in East Asians and Europeans Identified Multiple Therapeutic Targets for Ischemic Stroke
Yao P., Mazidi M., Pozarickij A. et al.
Olink Explore 3072/384
Biomarker Research, 2025The overlooked trio: sleep duration, sampling time and physical exercise alter levels of olink-assessed blood biomarkers of cardiovascular risk
Brandão L., Zhang L., Grip A. et al.
Olink Target 96
Scientific Reports, 2025Ophthalmological manifestations and plasma markers of inflammation in Ebola survivors in post-treatment era
Mwanza J., Kahindo A., Mbusa-Kombi J. et al.
Neurobiology of Disease, 2025Proximity extension assay reveals serum inflammatory biomarkers in two amyotrophic lateral sclerosis cohorts
Chen Y., Sun S., Gao N. et al.
Cancer Research, 2025Combining Spatial Transcriptomics, Pseudotime, and Machine Learning Enables Discovery of Biomarkers for Prostate Cancer
Smelik M., Diaz-Roncero Gonzalez D., An X. et al.
Cancer Medicine, 2025Direct Oral Anticoagulants Are Comparable to Low Molecular Weight Heparin at Sustaining the Circulating Extracellular Vesicle and Inflammatory Profiles of Cancer Associated Thrombosis Patients: An Observational Pilot Study
Macleod H., Copty N., Doherty D. et al.
Olink Target 48
Alzheimer's & Dementia, 2025Exploring inflammation‐related protein expression and its relationship with TSPO PET in Alzheimer's disease
Pola I., Ashton N., Antônio De Bastiani M. et al.
Nature Communications, 2025Dissecting cross-population polygenic heterogeneity across respiratory and cardiometabolic diseases
Yamamoto Y., Shirai Y., Sonehara K. et al.
Frontiers in Medicine, 2025Senolytic therapy reduces inflammation in epithelial cells from COPD patients and in smoke-exposure mice
Baker J., Daly L., Hassibi S. et al.
hLife, 2025Systemic profiling of immune responses in healthy adults vaccinated with an RBD-targeting COVID-19 mRNA vaccine
Zhou C., Sun M., Huang X. et al.
npj Aging, 2025Genetic determinants of proteomic aging
Mörseburg A., Zhao Y., Kentistou K. et al.
World Journal of Surgical Oncology, 2025Causal effect of gut microbiota on the risk of cancer and potential mediation by inflammatory proteins
Wang Y., Liu W., Liu L. et al.
eBioMedicine, 2025Quantifying temporal differences in the induction of interferon-mediated signalling observed in a dengue virus 1 human infection model: insights from longitudinal proteome analysis
Struyfs C., Van den Heede K., Van Wesenbeeck L. et al.
Olink Flex
Brain, 2025Markers of axonal injury in blood and tissue triggered by acute and chronic demyelination
Abdelhak A., Cordano C., Duncan G. et al.
International Journal of Molecular Sciences, 2025Significant Associations Between Blood Cell Counts and Plasma Cytokines, Chemokines, and Growth Factors
Eriksson L., Eriksson M., Gordh T. et al.
Cell Reports Medicine, 2025Cooking methods affect advanced glycation end products and lipid profiles: A randomized cross-over study in healthy subjects
Wellens J., Vissers E., Dumoulin A. et al.
Nature Communications, 2025Targeted plasma proteomics reveals organ damage signatures of AIDS- and noncommunicable disease-related deaths in people with HIV
Lin H., He J., Ren J. et al.
Communications Medicine, 2025Proteomics approach identifies aqueous humor biomarkers in retinal diseases
Huang K., Schofield C., Nguy T. et al.
European Heart Journal, 2025Finerenone effects on biomarkers: an analysis from the FIGARO-DKD trial
Berger M., MacNamara A., Ferreira J. et al.
Annals of Allergy, Asthma & Immunology, 2025Proteomic Profiling of Nasal Fluids and Serum for Type 2 Nasal Polyps Diagnosis
Hou Y., Chen C., Li Z. et al.
4455 publications
Items per page
1761-1780 of 4455 publications